1. Fogoros RN, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachy-arrhythmias. Ann Int Med 1987; 107: 635–641.
2. Tchou PJ, Kadri N, Andersen J, Caceres JA, Jazayeri M, Akthar M. Automatic implantable cardioverter defibrillator and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Int Med 1988; 109: 529–534.
3. Winkle RA, Mead RH, Ruder AM et al. Longterm outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989; 13: 1353–1361.
4. van den Oever R. Arrhythmia technology. The insurer’s point of view. In: Andries E, Brugada P, Stroobandt R, editors. How to face ‘the faces’ of cardiac pacing. Dordrecht, The Netherlands: Kluwer Academic Publishers, 1992: 255–265.
5. Brugada P, Van Royen M, Andries E, van den Oever R. The Belgian system to control indications for the implantable defibrillator: a model for other European countries?. Eur J Med 1993; 2: 86–88.